| Dr Kyle Charles Smith, DO | |
|
601 W Spruce St Ste J, Missoula, MT 59802 | |
| (406) 327-3350 | |
| (406) 327-3355 |
| Full Name | Dr Kyle Charles Smith |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 10 Years |
| Location | 601 W Spruce St Ste J, Missoula, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093135741 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 66644 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Patrick Hospital | Missoula, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Mt | 6608786306 | 272 |
News Archive
A simple and inexpensive psychotherapy or talking therapy known as behavioural activation (BA) is as effective at treating depression in adults as the gold-standard cognitive behavioural therapy (CBT), and can be delivered by non-specialist staff with minimal training at far less cost, according to new research published in The Lancet.
The President signed into law on Friday, June 25, 2010, The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act. The bill was approved by the U.S. House of Representatives by a vote of 417 to 1. The Senate had earlier approved the measure.
Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011.
Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.
› Verified 7 days ago
| Entity Name | Providence Health & Services Mt |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144319138 PECOS PAC ID: 6608786306 Enrollment ID: O20031229000787 |
News Archive
A simple and inexpensive psychotherapy or talking therapy known as behavioural activation (BA) is as effective at treating depression in adults as the gold-standard cognitive behavioural therapy (CBT), and can be delivered by non-specialist staff with minimal training at far less cost, according to new research published in The Lancet.
The President signed into law on Friday, June 25, 2010, The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act. The bill was approved by the U.S. House of Representatives by a vote of 417 to 1. The Senate had earlier approved the measure.
Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011.
Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Charles Smith, DO 601 W Spruce St Ste J, Missoula, MT 59802-4047 Ph: (406) 327-3350 | Dr Kyle Charles Smith, DO 601 W Spruce St Ste J, Missoula, MT 59802 Ph: (406) 327-3350 |
News Archive
A simple and inexpensive psychotherapy or talking therapy known as behavioural activation (BA) is as effective at treating depression in adults as the gold-standard cognitive behavioural therapy (CBT), and can be delivered by non-specialist staff with minimal training at far less cost, according to new research published in The Lancet.
The President signed into law on Friday, June 25, 2010, The Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act. The bill was approved by the U.S. House of Representatives by a vote of 417 to 1. The Senate had earlier approved the measure.
Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011.
Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.
› Verified 7 days ago
William D Stratford Jr., MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2831 Fort Missoula Road, Suite 305, Missoula, MT 59804 Phone: 406-327-4075 Fax: 406-327-4559 | |
John A. Willoughby, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 N Orange St, Suite 202, Missoula, MT 59802 Phone: 406-327-3362 Fax: 406-327-3349 | |
Dr. Jane Camerson Wells, M.D., M.H.S. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 700 South Ave W, Suite B, Missoula, MT 59801 Phone: 406-541-6220 Fax: 406-541-6221 | |
Nicholas Hurst, MD, MS Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 N Orange St Ste 202, Missoula, MT 59802 Phone: 406-377-3362 | |
Robert C. Munjal, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 902 N Orange St, Suite 206, Missoula, MT 59802 Phone: 406-327-3362 | |
Dr. Jason Rocco Molinaro, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 202, Missoula, MT 59802 Phone: 406-327-1670 Fax: 406-329-5697 |